Rating Rationale
July 20, 2022 | Mumbai
Hinduja Global Solutions Limited
Ratings continues on 'Watch Developing'
 
Rating Action
Total Bank Loan Facilities RatedRs.500 Crore
Long Term RatingCRISIL A+/Watch Developing (Continues on 'Rating Watch with Developing Implications')
Short Term RatingCRISIL A1+/Watch Developing (Continues on 'Rating Watch with Developing Implications')
 
Rs.125 Crore Commercial PaperCRISIL A1+/Watch Developing (Continues on 'Rating Watch with Developing Implications')
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings ratings on the bank facilities and commercial paper programme of Hinduja Global Solutions Limited (HGSL) continues on ‘Rating Watch with Developing Implications’.

 

CRISIL Ratings had placed the short-term rating on watch on January 25, 2021, following the announcement by the company board of directors on January 14, 2022, to allocate about Rs 1,000 crore from the proceeds received from sale of its healthcare vertical for a share buyback programme. Besides, the board also approved in principle the acquisition of the digital business of NXTDIGITAL Ltd (NDL), an associate company of the Hinduja group, through a share swap arrangement subject to regulatory and requisite approvals. As per the share exchange ratio finalised, the shareholders of NDL will receive 20 shares of HGS for every 63 NDL shares held. CRISIL Ratings continues to monitor these developments and will resolve the watch after discussion with HGSL management and receipt of necessary approvals.

 

NDL is the media vertical of the Hinduja group and its proposed acquisition is viewed as a strategic fit to enhance the digital share of business and customer experience. NDL delivers services via satellite, digital cable and broadband. It offers television services through a dual delivery platform consisting of digital cable and India’s only Headend In The Sky (HITS) satellite platform under the INDigital and NXTDIGITAL brands. NDL reported earnings before interest, tax, depreciation and amortisation (Ebitda) of Rs 212 crore and net profit of Rs 1.97 crore on revenue of Rs 1,152 crores in fiscal 2022.

 

On August 16, 2021, CRISIL Ratings had placed the long-term rating of HGSL on watch following the announcement on August 9, 2021, of the sale of its healthcare vertical to Baring Private Equity Asia, a private alternate investment firm, for an enterprise value of USD 1.2 billion (~Rs. 8900 crore), subject to adjustments. This transaction was completed in early January 2022. The healthcare vertical had over 20,000 employees across four geographies – India, the Philippines, the US and Jamaica – and registered revenue of ~USD 400 million in fiscal 2021 (~55% share of consolidated revenues).

 

The company has crystallised the amount to be utilised for buy-back at Rs 975 crore basis the audited fiscal 2022 results. Also, it paid dividend of Rs 195 per share by February 2022 and announced final dividend of Rs 25 per share (together amounting to Rs 512 crore). Moreover, it increased its lending to group companies in the form of inter corporate deposits (ICDs) to Rs 1,125 crore in March 2022 (maximum limit of Rs 1,930 crore for various categories of loans and investments as per Section 186 of the Companies Act) from Rs 389.5 crore in September 2021 (maximum limit of Rs 600 crore). A portion of the remaining Rs 5,991 crore as of March 2022 is expected to be deployed for the proposed buyback, expansion needs at NDL and future acquisitions. CRISIL Ratings will continue to monitor the fund deployment.

 

HGSL has also part-funded the acquisition of 100% equity in Diversify Offshore Staffing Solutions (DOSS, based in Brisbane, Australia), which will help gain foothold in the Australian market while increasing its strength in the Philippines. This transaction was completed in the fourth quarter of fiscal 2022.

 

Revenue (excluding healthcare business) at Rs 3,264 crore in fiscal 2022 registered a 25% on-year growth following strong client addition and deal wins. The Ebitda margin improved to 3.5% from 3.0% and has moderated compared with historical levels owing to higher legacy overheads,  manpower and related costs after the sale of the healthcare business. Revenue in the retained business segments (telecom, technology, consumer products, and banking and financial services) is expected to ramp up over the medium term with increased focus on customer acquisition and higher margin digital deals. With the DOSS acquisition, CRISIL Ratings expects HGSL’s revenue (excluding NDL) to grow by 15-16% in fiscal 2023 with Ebitda margin of about 6% supported by cost-optimisation measures.

 

The ratings continue to reflect the above-average business risk profile of HGSL, supported by presence in diverse verticals and geographies; and a strong financial risk profile because of comfortable debt protection metrics and adequate liquidity. These strengths are partially offset by exposure to intense competition in the business process management (BPM) industry, and high exposure to group companies.

Analytical Approach

CRISIL Ratings has combined the business and financial risk profiles of HGSL and all its subsidiaries, held directly or indirectly, as these entities have a common management and operate in the same business with significant operational and financial linkages. These entities are considered strategic to HGSL because of their strong integration with parent operations. The goodwill arising from acquisitions has been amortised over 10 years, and software and commercial rights (in line with company policy) over 3-6 years and 10 years, respectively.

 

Please refer Annexure List of Entities Consolidated, which highlights entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths

Above-average business risk profile and presence in diverse verticals: In the retained business too, the company is present across multiple verticals such as technology and telecom (20% share of fiscal 2022 revenue), consumer and retail (19%), banking and financial services (18%), media and entertainment (8%), chemicals and biotech (4%), and public sector and others (31%). Majority of revenue comes from the US (38% share in fiscal 2022), the UK (32%), and Canada (18%) followed by India (10%) and other countries. After divestment of the healthcare vertical, customer concentration has moderated as HGSL will have 200+ core BPM clients and 730+ clients in the payroll business. Adding clients in the telecom, e-commerce and media segments should bolster revenue over the medium term.

 

Healthy financial risk profile, including strong liquidity: Pre-payment of financial bank debt in fiscal 2022 and absence of large, debt-funded capital expenditure in the last few fiscals have helped to sustain a healthy capital structure: the company had nil debt (excluding lease liabilities) as on March 31, 2022, compared with Rs 394 crore in the previous fiscal. With moderation in EBITDA in fiscal 2022, Debt to EBITDA ratio has moderated to 2.72 times from 1.44 times last year despite repayment of debt. Capital spending may increase as HGSL pursues acquisitions and also because the business of NDL is capital intensive (debt of Rs 906 crore as on March 31, 2022; debt to Ebitda ratio of ~5 times). Though consolidated debt metrics are likely to moderate after the acquisition of NDL’s business, these will remain adequate.

 

Liquid surplus was Rs 5,991 crore as on March 31, 2022, bolstered by proceeds from the sale of the healthcare business and residual cash accrual (after interim dividend payout and ICDs to group companies). The actual deployment and balance of funds left after acquisitions, investments in group companies, expansion by NDL and other developments will remain key credit monitorable.

 

Weaknesses

Exposure to intensifying competition that impacts price flexibility and cost management: The information technology-enabled services industry is highly competitive. Quality, price, reliability, range of services and data security technology determine margins. HGSL has to compete with established players such as Genpact, WNS (Holding) Ltd and Firstsource Solutions Ltd (‘CRISIL A+/Stable/CRISIL A1’). Also, increasing wages and costs associated with hiring, training and retaining talent pose challenges for adequate staffing and seat utilisation. Profitability will remain susceptible to competition, rising employee cost and the ability to transfer any cost increase to customers.

 

High exposure to group companies: In recent years, HGSL has invested Rs 315-492 crore in group companies (Hinduja Group Ltd(HGL), Hinduja Realty Ventures Ltd(HRVL), Hinduja Energy India Ltd and NDL), which generate higher return compared to fixed deposits; the loans are returnable on call. Though exposure to group companies increased substantially to Rs 1,630 crore in January 2022, it reduced to Rs 1,214 crore in June 30, 2022, including lending to HGL, HRVL, and NDL. Any sharp increase in exposure to group companies will be a monitorable.

Liquidity: Strong

Liquid surplus was Rs 5,991 crore as on March 31, 2002, backed by divestment receipts of healthcare vertical, post-payment of dividend and ICDs of Rs 1,125 crore to group companies. Working capital limit of Rs 325 crore was unutilised in the six months through June 2021 and the company fully repaid all its long-term debt obligation by March 2022. If the merger of the digital business of NDL goes through, part of the surpluses may be deployed for organic growth at NDL. Besides, HGSL will also continue to pursue inorganic growth opportunities. Sustenance of adequate liquid surpluses will be a key monitorable.

Rating Sensitivity Factors

Upward Factors:

  • Sustained healthy revenue growth for existing business, and double-digit operating profitability
  • Maintenance of strong financial risk profile and debt metrics while pursuing organic and inorganic growth and after acquisition of NDL; and steady state debt to Ebitda of below 1-1.25 times
  • Ensuring material liquid surpluses post acquisitions, ICDs to group companies, buyback and dividend

 

Downward Factors:

  • Sluggish performance of residual businesses and NDL impacting operating profitability (below 5-6% on a steady-state basis) and cash generation
  • Large, debt-funded acquisitions impacting financial risk profile and key debt metrics; steady state debt to Ebitda remaining above 2.5 times
  • Sizeable reduction in liquid surplus to fund growth opportunities/share buyback/dividend payout over the medium term
  • Substantial increase in exposure to group companies

About the Company

HGSL is a part of the Hinduja group that includes Ashok Leyland Ltd, HLFL, Hinduja Housing Finance Ltd (‘CRISIL AA-/Stable/CRISIL A1+’), Hinduja Renewables Energy Pvt Ltd (‘CRISIL AA-/Stable/CRISIL A1+’) and IndusInd Bank Ltd ('CRISIL AA+/CRISIL AA/Stable/CRISIL A1+'). The company provides BPM services, primarily back-office processing and contact centre, to domestic and international clients. As on March 31, 2022, it had 38 delivery centres in seven countries and ~22, 000 employees.

 

During fiscal 2022, HGSL reported a profit after tax (PAT) of Rs 6,104 crore (Rs 336 crore in fiscal 2021) on revenue of Rs 3,264 crore (Rs 5,638 crore).

Key Financial Indicators (CRISIL Ratings-adjusted)

Particulars

Unit

2022 (Provisional)

2021 (Actual)

Operating income

Rs.Crore

3,264

5,638

PAT

Rs.Crore

6104

336

PAT margin

%

187

6.0

Interest coverage

Times

9.53

9.67

Adjusted debt (excluding lease liabilities)/adjusted networth

Times

0.00

0.23

Adjusted debt /adjusted networth

Times

0.04

0.70

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings' complexity levels are assigned to various types of financial instruments. The CRISIL Ratings' complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL Ratings' complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of instrument

Date of allotment

Coupon rate (%)

Maturity date

Issue size (Rs.Cr)

Complexity Level

Rating assigned with outlook

NA

Commercial Paper

NA

NA

7-365 days

125.00

Simple

CRISIL A1+/Watch Developing

NA

Cash Credit*

NA

NA

NA

280.00

NA

CRISIL A+/Watch Developing

NA

Packing Credit

NA

NA

NA

75.00

NA

CRISIL A1+/Watch Developing

NA

Proposed Working Capital Facility

NA

NA

NA

20.00

NA

CRISIL A+/Watch Developing

NA

Proposed Term Loan

NA

NA

NA

125.00

NA

CRISIL A+/Watch Developing

*Interchangeable with post-shipment credit and other working capital financing instruments

Annexure - List of Entities Consolidated

Sr.No

Name of the entity

Extent of consolidation

Rationale for consolidation

1

Hinduja Global Solutions Ltd

Full

Holding

2

HGS International

Full

Co-subsidiary

3

Hinduja Global Solutions Inc

Full

Co-subsidiary

4

HGS Properties LLC

Full

Co-subsidiary

5

HGS Canada Holdings LLC

Full

Co-subsidiary

6

HGS Canada Inc

Full

Co-subsidiary

7

HGS EBOS LLC

Full

Co-subsidiary

8

HGS (USA) LLC

Full

Co-subsidiary

9

HGS Healthcare LLC

Full

Co-subsidiary

10

Affina Company

Full

Co-subsidiary

11

Hinduja Global Solutions Europe Ltd

Full

Co-subsidiary

12

Hinduja Global Solutions UK Ltd

Full

Co-subsidiary

13

HGS France S.A.R.L

Full

Co-subsidiary

14

C-Cubed N.V

Full

Co-subsidiary

15

C-Cubed B.V

Full

Co-subsidiary

16

Customer Contact Centre Inc.

Full

Co-subsidiary

17

HGS St. Lucia Ltd

Full

Co-subsidiary

18

Team HGS Ltd

Full

Co-subsidiary

19

Hinduja Global Solutions MENA FZ LLC

Full

Co-subsidiary

20

HGS Colibrium Inc

Full

Co-subsidiary

21

HGS Digital Solutions LLC

Full

Co-subsidiary

22

HGS Axis Point Helath LLC

Full

Co-subsidiary

23

Falcon Health Solutions Puerto Rico Holding LLC

Full

Co-subsidiary

24

Falcon Health Solutions Puerto Rico LLC

Full

Co-subsidiary

Annexure - Rating History for last 3 Years
  Current 2022 (History) 2021  2020  2019  Start of 2019
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT/ST 500.0 CRISIL A1+/Watch Developing / CRISIL A+/Watch Developing 22-04-22 CRISIL A1+/Watch Developing / CRISIL A+/Watch Developing 08-12-21 CRISIL A1+ / CRISIL A+/Watch Developing 31-03-20 CRISIL A1+ / CRISIL A+/Stable 14-03-19 CRISIL A1+ / CRISIL A+/Stable CRISIL A1+ / CRISIL A+/Stable
      -- 25-01-22 CRISIL A1+/Watch Developing / CRISIL A+/Watch Developing 15-11-21 CRISIL A1+ / CRISIL A+/Watch Developing   --   -- CRISIL A+/Stable
      --   -- 17-08-21 CRISIL A1+ / CRISIL A+/Watch Developing   --   -- --
      --   -- 30-03-21 CRISIL A1+ / CRISIL A+/Positive   --   -- --
Commercial Paper ST 125.0 CRISIL A1+/Watch Developing 22-04-22 CRISIL A1+/Watch Developing 08-12-21 CRISIL A1+ 31-03-20 CRISIL A1+ 14-03-19 CRISIL A1+ CRISIL A1+
      -- 25-01-22 CRISIL A1+/Watch Developing 15-11-21 CRISIL A1+   --   -- --
      --   -- 17-08-21 CRISIL A1+   --   -- --
      --   -- 30-03-21 CRISIL A1+   --   -- --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Cash Credit* 30 ICICI Bank Limited CRISIL A+/Watch Developing
Cash Credit* 100 Axis Bank Limited CRISIL A+/Watch Developing
Cash Credit* 150 HDFC Bank Limited CRISIL A+/Watch Developing
Packing Credit 75 YES Bank Limited CRISIL A1+/Watch Developing
Proposed Term Loan 125 Not Applicable CRISIL A+/Watch Developing
Proposed Working Capital Facility 20 Not Applicable CRISIL A+/Watch Developing
This Annexure has been updated on 20-Jul-2022 in line with the lender-wise facility details as on 07-Dec-2021 received from the rated entity
*Interchangeable with post-shipment credit and other working capital financing instruments
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Software Industry
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Anuj Sethi
Senior Director
CRISIL Ratings Limited
B:+91 44 6656 3100
anuj.sethi@crisil.com


Aditya Jhaver
Director
CRISIL Ratings Limited
B:+91 22 3342 3000
Aditya.Jhaver@crisil.com


Ashish Kumar
Manager
CRISIL Ratings Limited
B:+91 22 3342 3000
Ashish.Kumar1@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL’s privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale (‘report’) that is provided by CRISIL Ratings Limited (‘CRISIL Ratings’). To avoid doubt, the term ‘report’ includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, ‘CRISIL Ratings Parties’) guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html